Sign in to fuzzto save your conversations, follow your research and come back anytime.
Beta Drugs
SectorHealthcare
| Metric (₹ crore) | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|
| Sales | 88.29 | 93.76 | 100.21 | 103.39 | 87.27 | 93.96 | 125.55 |
| Expenses | 69.83 | 76.42 | 80.5 | 82.08 | 70.28 | 76.29 | 98.18 |
| EBITDA | 18.46 | 17.34 | 19.71 | 21.31 | 16.99 | 17.67 | 27.37 |
| Depreciation | 3.24 | 3.57 | 3.73 | 4.24 | 4.39 | 4.8 | 4.35 |
| EBIT | 15.22 | 13.77 | 15.98 | 17.07 | 12.6 | 12.87 | 23.02 |
| Interest | 1.88 | 3.29 | 3.32 | 3.61 | 4.43 | 3.94 | 2.56 |
| Profit Before Tax | 13.34 | 10.48 | 12.66 | 13.46 | 8.17 | 8.93 | 20.46 |
| Net Profit | 8.95 | 9.03 | 11.7 | 12.22 | 8.52 | 9.05 | 16.49 |
| EPS | 9.31 | 9.4 | 11.59 | 12.1 | 8.4 | 8.93 | 14.78 |
| Metric (₹ crore) | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 17.1 | 0.11 | 8.41 | 18.6 | 29.63 | 23.38 | 30.93 | 36.14 |
| Investing Cash Flow | -10.79 | -20.78 | -15.05 | -5.85 | -21.75 | -19.07 | -13.97 | -35.72 |
| Financing Cash Flow | 5.45 | 12.07 | 8.73 | -7.71 | -0.97 | -2.47 | -7.49 | 117.97 |
| Net Cash Flow | 11.76 | -8.6 | 2.09 | 5.04 | 6.91 | 1.84 | 9.47 | 118.39 |
| Metric (₹ crore) | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 32.88 | 40.92 | 57.11 | 68.61 | 92.34 | 122.88 | 157.12 | 197.1 |
| Total Liabilities | 16.7 | 41.62 | 50.06 | 48.89 | 65.51 | 75.54 | 96.98 | 239.14 |
| Total Assets | 49.58 | 82.54 | 107.18 | 117.5 | 157.85 | 198.42 | 254.1 | 436.24 |